Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
Q2 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
Q4 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
Co-Diagnostics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.32 earnings per share for the quarter, topping analysts' consensus estimates of $-0.33 by $0.01. The company had revenue of 641,141 for the quarter and had revenue of 6.81 M for the year. Co-Diagnostics, Inc. has generated $-1 earnings per share over the last year ($-1.2 diluted earnings per share) and currently has a price-to-earnings ratio of -0.57. Co-Diagnostics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.33 | -$0.32 | 0.01 | $375,000 | $641,141 |
08/08/2024 | Q2 2024 | -$0.34 | -$0.25 | 0.09 | $400,000 | $161,102 |
05/09/2024 | Q1 2024 | -$0.21 | -$0.31 | -0.1 | $252,745 | |
03/14/2024 | Q4 2023 | -$0.20 | -$0.47 | -0.27 | $3.56 M | |
11/09/2023 | Q3 2023 | -$0.29 | -$0.20 | 0.09 | $200,000 | $2.46 M |
08/10/2023 | Q2 2023 | -$0.24 | -$0.31 | -0.07 | $500,000 | $197,806 |
05/11/2023 | Q1 2023 | -$0.23 | -$0.20 | 0.03 | $601,957 | |
03/16/2023 | Q4 2022 | -$0.15 | -$0.71 | -0.56 | $1.40 M | |
11/10/2022 | Q3 2022 | -$0.06 | -$0.04 | 0.02 | $7.48 M | $5.09 M |
08/11/2022 | Q2 2022 | $0.15 | -$0.08 | -0.23 | $15.34 M | $5.02 M |
05/12/2022 | Q1 2022 | $0.18 | $0.35 | 0.17 | $22.70 M | |
03/24/2022 | Q4 2021 | $0.12 | $0.26 | 0.14 | $20.40 M | |
11/12/2021 | Q3 2021 | $0.40 | $24.32 M | $30.10 M | ||
08/12/2021 | Q2 2021 | $0.22 | $0.34 | 0.12 | $20.77 M | $27.36 M |
05/13/2021 | Q1 2021 | $0.22 | $0.28 | 0.06 | $20.02 M | |
03/25/2021 | Q4 2020 | $0.48 | $0.46 | -0.02 | $27.15 M | |
11/16/2020 | Q3 2020 | $0.63 | $0.56 | -0.07 | $32.80 M | $21.82 M |
08/13/2020 | Q2 2020 | $0.59 | $0.54 | -0.05 | $26.45 M | $24.04 M |
05/14/2020 | Q1 2020 | -$0.05 | -$0.05 | 0 | $1.55 M | |
03/30/2020 | Q4 2019 | -$0.08 | $108,566 |
Co-Diagnostics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
In the previous quarter, Co-Diagnostics, Inc. (:CODX) reported $-0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.33 by $0.01.
The conference call for Co-Diagnostics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Co-Diagnostics, Inc.'s latest earnings report can be read online.
Co-Diagnostics, Inc. (:CODX) has a recorded annual revenue of $6.81 M.
Co-Diagnostics, Inc. (:CODX) has a recorded net income of $6.81 M. Co-Diagnostics, Inc. has generated $-1.2 earnings per share over the last four quarters.
Co-Diagnostics, Inc. (:CODX) has a price-to-earnings ratio of -0.57 and price/earnings-to-growth ratio is 0.06.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED